Inside CVS Caremark’s move that broke Humira’s hold on the market

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.)

For the first time in April, biosim­i­lars start­ed to gain a larg­er share of the Hu­mi­ra mar­ket. Up un­til that point, the mar­ket felt unim­peach­able, with Ab­b­Vie’s Hu­mi­ra re­tain­ing 96% of the share by Feb­ru­ary. That changed when Hu­mi­ra came off the for­mu­la­ry of CVS Health’s phar­ma­cy ben­e­fit man­ag­er Care­mark.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.